BRAF V600E Mutation and MET Amplification As Resistance Pathways of the Second-Generation Anaplastic Lymphoma Kinase (ALK) Inhibitor Alectinib in Lung Cancer.
Lung Cancer（2020）
Key words
Lung adenocarcinoma,Patient-derived xenograft,PDX,EML4-ALKv1,ALK inhibitor,Drug resistance,NOD-SCID mice,Dabrafenib,Capmatinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined